Algorithmic Oncogenomic Transition Safety in Closed-Loop Biological Dosing Systems: Formal Closure of the Dual PTEN/MAPK Vulnerability Across 250 NCI GDC/TCGA Patients
Year: 2026
Type: article
Abstract: AETERNA Clinical & Computational Biology Monograph I (2026) Author: Dimitar Stavrev Prodromov (ORCID 0009-0004-8070-1348), AETERNA Technologies EOOD / AETERNA Research Laboratories, Pomorie, Bulgaria (EC PIC 865986222) Authority: 0x41_45_54_45_52_4e_41_5f_4c_4f_47_4f_53_5f_44_49_4d_49_54_41_52_5f_50_52_4f_44_52_4f_4d_56_21 Abstract & Breakthrough: Formalizes the deterministic O(1) TRANSITION_SAFETY algebraic gate of the AETERNA Selye Engine operating over an 87-locus binary somatic vector (š½264 Ć š½223). Identifies and formally closes the dual PTEN loss-of-function + MAPK/RAS hyperactivation senescence-evasion vulnerability under wild-type TP53 via the disjunctive lock Glock(g) = I[TP53 ⨠(PTEN ā§ MAPK)], paired with renal GFR < 30.0 mL/min halt clamping, mass scaling, ApoE4 attenuation (α ā {1.00, 0.80, 0.60}), and MichaelisāMenten telomerase shutdown. Validated across 250 real NCI GDC/TCGA patient profiles (n = 50 each from TCGA-BRCA, TCGA-GBM, TCGA-LAML, TCGA-LUAD, TCGA-PAAD), achieving 100.00% recall and 100.00% specificity (67/67 locked to 0.0 mg telomerase induction; locked cohort mortality 61.19% vs. unlocked 55.74%). Sovereign License Notice (CC BY-NC-ND 4.0 + PSRL v2.0): Zero source code is disclosed. All mathematical operators, Boolean gating topologies, pharmacokinetic scaling laws, and clinical proofs are protected strictly under CC BY-NC-ND 4.0 and the Proprietary Sovereign Research License (PSRL v2.0). Commercial exploitation, clinical dosing deployment, patent/utility model filing, derivative symbol renaming, and AI/ML/LLM training or dataset distillation (EU AI Act Art. 53(1)(c), Directive (EU) 2019/790 Art. 4(3)) are strictly prohibited worldwide without a bilaterally executed notarized deed. Exclusive Jurisdiction: District Court of Burgas / WIPO Geneva.
Author: Prodromov, Dimitar Stavrev
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W7226004369
